Hoth Therapeutics Inc. (NASDAQ: HOTH) shares gained 12.9% after the company signed a Sponsored Research Agreement with Washington University to support research and development of HT-ALZ- HT-ALZ is a novel treatment for Alzheimer’s disease symptoms.  Hoth Therapeutics partners with Washington University School of Medicine  Washington University School of Medicine’s Carla […]